Advances in antitumor effects of NSAIDs
- PMID: 30410398
- PMCID: PMC6197827
- DOI: 10.2147/CMAR.S175212
Advances in antitumor effects of NSAIDs
Abstract
In recent years, the reports on using nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer prevention and treatment have been on the rise. In 2017, the US Preventive Services Working Group issued primary prevention guidelines on the use of NSAIDs, especially aspirin, for cardiovascular disease and colorectal cancer, and formally established the role and status of aspirin in cancer prevention. However, the mechanism of NSAIDs on preventing cancer is still not clear. In this paper, the progress of the application of NSAIDs, especially aspirin, in the prevention and treatment of tumors in recent years is summarized, and new ideas and directions for the follow-up study are also discussed.
Keywords: NSAIDs; aspirin; cancer; platelets.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Similar articles
-
Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention.Gastroenterol Clin North Am. 1996 Dec;25(4):773-91. doi: 10.1016/s0889-8553(05)70274-0. Gastroenterol Clin North Am. 1996. PMID: 8960892 Review.
-
Colorectal cancer and nonsteroidal anti-inflammatory drugs.Adv Pharmacol. 1997;39:1-20. doi: 10.1016/s1054-3589(08)60067-8. Adv Pharmacol. 1997. PMID: 9160111 Review.
-
NSAIDs and gastrointestinal cancer prevention.Drugs. 2002;62(6):945-56. doi: 10.2165/00003495-200262060-00006. Drugs. 2002. PMID: 11929340 Review.
-
Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers.Aliment Pharmacol Ther. 2008 Nov 15;28(10):1249-58. doi: 10.1111/j.1365-2036.2008.03836.x. Epub 2008 Aug 22. Aliment Pharmacol Ther. 2008. PMID: 18729848
-
Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.Important Adv Oncol. 1996:123-37. Important Adv Oncol. 1996. PMID: 8791132 Review.
Cited by
-
The Potential Preventive and Therapeutic Roles of NSAIDs in Prostate Cancer.Cancers (Basel). 2023 Nov 16;15(22):5435. doi: 10.3390/cancers15225435. Cancers (Basel). 2023. PMID: 38001694 Free PMC article. Review.
-
Indomethacin Induces Spermidine/Spermine-N1-Acetyltransferase-1 via the Nucleolin-CDK1 Axis and Synergizes with the Polyamine Oxidase Inhibitor Methoctramine in Lung Cancer Cells.Biomolecules. 2023 Sep 12;13(9):1383. doi: 10.3390/biom13091383. Biomolecules. 2023. PMID: 37759783 Free PMC article.
-
Prognostic Value of Post-Operative C-Reactive Protein-Based Inflammatory Biomarkers in Colorectal Cancer Patients: Systematic Review and Meta-Analysis.Clin Epidemiol. 2023 Jun 27;15:795-809. doi: 10.2147/CLEP.S415171. eCollection 2023. Clin Epidemiol. 2023. PMID: 37396024 Free PMC article. Review.
-
Survival Analysis of 1140 Patients with Biliary Cancer and Benefit from Concurrent Renin-Angiotensin Antagonists, Statins, or Aspirin with Systemic Therapy.Oncologist. 2023 Jun 2;28(6):531-541. doi: 10.1093/oncolo/oyad063. Oncologist. 2023. PMID: 37036699 Free PMC article.
-
Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing.Pharmaceuticals (Basel). 2023 Mar 16;16(3):451. doi: 10.3390/ph16030451. Pharmaceuticals (Basel). 2023. PMID: 36986550 Free PMC article. Review.
References
-
- Yujie G. Clinical application and safety evaluation of non-steroidal anti-inflammatory drugs. Pract Pharm Clin Remedies. 2009;02:122–124.
-
- Kang SU, Lee BS, Lee SH, Baek SJ, Shin YS, Kim CH. Expression of NSAID-activated gene-1 by EGCG in head and neck cancer: involvement of ATM-dependent p53 expression. J Nutr Biochem. 2013;24(6):986–999. - PubMed
-
- Kawahara T, Ishiguro H, Hoshino K, et al. Analysis of NSAID-activated gene 1 expression in prostate cancer. Urol Int. 2010;84(2):198–202. - PubMed
-
- Retsky M, Rogers R, Demicheli R, et al. NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup. Breast Cancer Res Treat. 2012;134(2):881–888. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
